MedAware has been selected by Allscripts patient safety and save lives. This is significant as new interoperability challenges arise created by an all-digital healthcare system.
In the US alone, 1.5 million prescription errors per year result in injury or death. Nearly every organization has an EHR and physicians are being bombarded by huge stores of patient data. Allscripts has selected MedAware as its partner to put this data to work – to achieve meaningful interoperability and improve care in a single actionable patient record.
In order to provide actionable insights at the point of care and after the script was already filled, MedAware monitors patients’ clinical records to detect medication-related risks, evolving adverse drug events (ADEs), and to identify patient-specific risk of opioid dependency with unprecedented accuracy. As a result, in live clinical settings, providers mostly choose to revise their prescriptions when they are notified of such risks from MedAware.
This level of success is achieved by using the company’s patented medication monitoring technology that leverages machine-learning algorithms and outlier detection mechanisms to identify adverse drug events and flag potentially life-threatening prescriptions that are in conflict with the profile of the patient, physician, or institution.
“MedAware is excited to collaborate with a leading global EHR vendor so prominently known for its focus on safety and healthcare innovation,” said Dr. Gidi Stein, MedAware’s co-founder and CEO. “This partnership is a huge milestone for MedAware. We look forward to demonstrating the impact our clinical monitoring technology will have on providing safer patient care and helping to curb the opioid epidemic that continues to devastate families and communities throughout the US.”
